Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

Core Insights - Legend Biotech Corporation will host a conference call on November 12, 2025, at 8:00 am ET to discuss its third quarter 2025 results [1] - The company is a leader in cell therapy, particularly known for its CAR-T cell therapy product, CARVYKTI, for treating relapsed or refractory multiple myeloma [3] Company Overview - Legend Biotech employs over 2,800 individuals and is recognized as the largest standalone cell therapy company [3] - The company collaborates with Johnson & Johnson to develop and market CARVYKTI, aiming to enhance patient access and therapeutic potential [3] - Legend Biotech is focused on expanding its leadership in the cell therapy sector and driving future innovations across its pipeline [3]